查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1645704

全球稳定同位素标记化合物市场（按类型、应用和最终用户）- 机会分析和产业预测，2024 年至 2035 年

Stable Isotope Labeled Compounds Market By Type, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2024-2035
出版日期: | 出版商: Allied Market Research | 英文 317 Pages | 商品交期: 2-3个工作天内

价格
简介目录

稳定同位素标记化合物市值预计在 2023 年达到 2.9182 亿美元，到 2035 年将达到 4.201 亿美元，2024 年至 2035 年的复合年增长率为 3.1%。

稳定同位素标记化合物是其中一个或多个原子被非放射性同位素取代的分子，例如碳-13（^13C）、氮-15（^15N）或氘（^2H）。这些同位素在化学上与自然界中的同位素相同，但原子质量不同，因此可以在不发射辐射的情况下进行追踪。它们广泛应用于研究和工业应用，在研究代谢途径、药物开发和环境过程方面发挥重要作用。由于它不具有放射性，因此可安全地用于生物和化学分析，并能为深入了解分子行为、反应机制和相互作用提供有价值的见解。

稳定同位素标记化合物市场的成长受到各种相互关联的因素的显着影响，这些因素增加了效用。对质谱和核磁共振（NMR）等先进分析技术日益增长的需求发挥着至关重要的作用。这些技术在很大程度上依赖稳定同位素标记化合物来实现精确的测量和高分辨率的分析，从而促进它们的应用。随着研究和诊断应用变得越来越复杂，对准确可靠的分析工具的需求也日益增加，进一步推动了市场的成长。此外，稳定同位素标记化合物在环境研究中的应用日益广泛，凸显了它们的多功能性。这些化合物用于追踪污染物和监测环境变化，为监管和环境保护工作提供重要资料。这些应用将增加稳定同位素标记化合物在应对全球环境挑战的重要性，从而推动市场成长。

稳定同位素标记化合物市场-IMG1

临床试验和蛋白质体学研究的扩展是另一个重要驱动力。稳定同位素标记化合物对于了解药物代谢和生物系统内的复杂相互作用至关重要。在临床试验中，它有助于追踪新药的代谢途径；在蛋白质体学中，它可以实现蛋白质的精确量化和追踪。临床和蛋白质组学应用的成长反映了人们越来越依赖这些化合物来推动医学研究和个人化医疗。

此外，研究人员和临床医生对稳定同位素标记化合物的认识和采用不断提高也是推动市场成长的主要因素。随着研究人员和临床医生越来越熟悉稳定同位素标记化合物的优点，例如它们能够提高各种研究的准确性和可靠性，这些化合物的使用正在增加。人们对此类稳定同位素标记化合物的价值的认识不断提高，进一步促进了各个科学和临床领域的需求增加，产生了推动整个市场成长的协同效应。

稳定同位素标记化合物市场分为类型、应用、最终用户和地区。根据类型，市场分为氘、碳-13、氧-18、氮-15 和其他。根据应用，市场分为研究、临床诊断和其他。研究部分进一步分为生物医学研究、药物研究和其他。根据最终用户，市场细分为製药和生物技术公司、学术和研究机构、医院和诊断中心以及其他最终用户。根据地区，市场分析涵盖北美、欧洲、亚太、拉丁美洲、中东和非洲。

相关人员的主要利益

  • 本报告定量分析了 2023 年至 2035 年稳定同位素标记化合物市场分析的市场细分、当前趋势、估计、趋势和动态，并确定了突出的稳定同位素标记化合物市场机会。
  • 它为市场研究提供与市场驱动因素、市场限制因素和市场机会相关的资讯。
  • 波特五力分析强调了买家和供应商的潜力，使相关人员能够做出利润驱动的商业决策并加强供应商-买家网络。
  • 对稳定同位素标记化合物市场细分的详细分析有助于发现市场机会。
  • 每个地区的主要国家都根据收益贡献进行划分。
  • 市场公司的定位有利于基准化分析，并能清楚了解市场公司的当前地位。
  • 它包括对区域和全球稳定同位素标记化合物市场趋势、主要企业、细分市场、应用领域和市场成长策略的分析。

此报告可进行客製化（需支付额外费用和时间表）

  • 国家、地区和全球层面的患者/流行病学资料
  • 监管指南
  • 根据客户兴趣提供额外的公司简介
  • 按国家或地区进行的额外分析 - 市场规模和预测
  • 扩展公司简介列表
  • 历史市场资料
  • SWOT 分析

目录

第 1 章 简介

第 2 章执行摘要

第三章 市场概况

  • 市场定义和范围
  • 主要发现
    • 关键影响因素
    • 重大投资机会
  • 波特五力分析
  • 市场动态
    • 驱动程式
      • 癌症发生率上升及研究进展
      • 增加政府资金和支持
      • 主要企业越来越多地采用这些策略
    • 限制因素
      • 製造成本高且技术复杂
    • 机会
      • 新兴国家的成长机会

第四章。

  • 概述
  • 氘
  • 碳13
  • 氧气 18
  • 氮 15
  • 其他的

第五章稳定同位素标记化合物市场（依应用）

  • 概述
  • 研究
    • 稳定同位素标记化合物市场研究类型
  • 临床诊断
  • 其他的

第六章。

  • 概述
  • 製药和生物技术公司
  • 学术和研究机构
  • 医院和诊断中心
  • 其他的

7. 稳定同位素标记化合物市场（按地区）

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 其他的
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 其他的
  • 拉丁美洲、中东和非洲
    • 巴西
    • 南非
    • 沙乌地阿拉伯
    • 其他的

第八章 竞争格局

  • 介绍
  • 关键成功策略
  • 前 10 家公司的产品图谱
  • 竞争仪錶板
  • 竞争热图
  • 2023年主要企业的定位

第九章 公司简介

  • Merck KGaA
  • Otsuka Holdings Co., Ltd.
  • Entegris
  • Omicron Biochemicals, Inc.
  • Shimadzu Corporation
  • Silantes
  • VIVAN Life Sciences
  • BOC Sciences
  • Symeres
  • NIPPON SANSO HOLDINGS CORPORATION
简介目录
Product Code: A07585

The stable isotope labeled compounds market was valued at $291.82 million in 2023 and is estimated to reach $420.1 million by 2035, exhibiting a CAGR of 3.1% from 2024 to 2035. Stable isotope-labeled compounds are molecules where one or more atoms are replaced with non-radioactive isotopes, such as carbon-13 (^13C), nitrogen-15 (^15N), deuterium (^2H), and others. These isotopes are chemically identical to their naturally occurring counterparts but differ in atomic mass, allowing them to be tracked without emitting radiation. Widely used in research and industrial applications, they play a crucial role in studying metabolic pathways, drug development, and environmental processes. Their non-radioactive nature makes them safe for use in both biological and chemical analyses, providing valuable insights into molecular behavior, reaction mechanisms, and interactions at a detailed level.

The growth of the stable isotope-labeled compounds market is significantly influenced by a range of interconnected factors that enhance its utility across various fields. The rise in demand for advanced analytical techniques such as mass spectrometry and nuclear magnetic resonance (NMR) plays a pivotal role. These techniques rely majorly on stable isotope-labeled compounds to achieve precise measurements and high-resolution analysis, thus driving their adoption. The need for accurate and reliable analytical tools increases, as research and diagnostic applications become sophisticated, further fueling market growth. In addition, the increase in application of stable isotope-labeled compounds in environmental studies highlights their versatility. These compounds are used to trace pollutants and monitor environmental changes, providing crucial data for regulatory and conservation efforts. This application drives the growing importance of stable isotope-labeled compounds in addressing global environmental challenges, thus fostering the market growth.

Stable Isotope Labeled Compounds Market - IMG1

The expansion of clinical trials and proteomics studies represents another crucial driver. Stable isotope-labeled compounds are essential for understanding drug metabolism and the complex interactions within biological systems. In clinical trials, they help in tracing the metabolic pathways of new drugs, while in proteomics, they enable precise protein quantification and tracking. This growth in clinical and proteomics applications reflects the increasing reliance on these compounds for advancing medical research and personalized medicine.

Moreover, the rise in awareness and adoption of stable isotope-labeled compounds among researchers and clinicians is a key factor driving the market growth. There is an increase in the usage of these compounds as researchers and clinicians become familiar with the benefits associated with them, including their ability to enhance accuracy and reliability in various studies. This growing recognition of the value of stable isotope-labeled compounds further contributes to their increasing demand across diverse scientific and clinical fields, creating a synergistic effect that drives the overall market growth.

The stable isotope-labeled compounds market is segmented into type, application, end user, and region. On the basis of type, the market is segmented into Deuterium, Carbon-13, Oxygen-18, Nitrogen-15, and others. On the basis of application, the market is classified into research, clinical diagnostics, and other. The research segment is further divided into biomedical research, pharma research, and others. On the basis of end user, the market is categorized into pharmaceutical and biotechnology companies, academic and research institutes, hospitals and diagnostic centers, and other end users. On the basis of region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The major companies profiled in the report include Merck KGaA, Otsuka Holdings Co., Ltd., Entegris, Omicron Biochemicals, Inc., Shimadzu Corporation, Nippon Sanso Holding Corporation, Vivan Life Sciences, BOC Sciences, Silantes, and Symeres. The key players have adopted product launch, geographical expansion, partnership, and agreement as the key strategies to expand their product portfolio.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the stable isotope labeled compounds market analysis from 2023 to 2035 to identify the prevailing stable isotope labeled compounds market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the stable isotope labeled compounds market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global stable isotope labeled compounds market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Patient/epidemiology data at country, region, global level
  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • SWOT Analysis

Key Market Segments

By Type

  • Deuterium
  • Carbon 13
  • Oxygen 18
  • Nitrogen15
  • Other

By Application

  • Research
    • Type
    • Biomedical Research
    • Pharma Research
    • Others
  • Clinical Diagnostics
  • Others

By End User

  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Hospitals and Diagnostic Centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa,
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • BOC Sciences
    • Entegris
    • Merck KGaA
    • NIPPON SANSO HOLDINGS CORPORATION
    • Omicron Biochemicals, Inc.
    • Otsuka Holdings Co., Ltd.
    • Shimadzu Corporation
    • Silantes
    • Symeres
    • VIVAN Life Sciences

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Moderate bargaining power of suppliers
    • 3.3.2. Moderate threat of new entrants
    • 3.3.3. Moderate threat of substitutes
    • 3.3.4. Moderate intensity of rivalry
    • 3.3.5. Moderate bargaining power of buyers
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Rise in Cancer Prevalence and Advancements in Research
      • 3.4.1.2. Growing Government Funding and Support
      • 3.4.1.3. Rise in adoption of strategies by the key players
    • 3.4.2. Restraints
      • 3.4.2.1. High Production Costs and Technical Complexity
    • 3.4.3. Opportunities
      • 3.4.3.1. Growth Opportunity in emerging countries

CHAPTER 4: STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Deuterium
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Carbon 13
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. Oxygen 18
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country
  • 4.5. Nitrogen15
    • 4.5.1. Key market trends, growth factors and opportunities
    • 4.5.2. Market size and forecast, by region
    • 4.5.3. Market share analysis by country
  • 4.6. Other
    • 4.6.1. Key market trends, growth factors and opportunities
    • 4.6.2. Market size and forecast, by region
    • 4.6.3. Market share analysis by country

CHAPTER 5: STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY APPLICATION

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Research
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
    • 5.2.4. Research Stable Isotope Labeled Compounds Market by Type
  • 5.3. Clinical Diagnostics
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Others
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country

CHAPTER 6: STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END USER

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Pharmaceutical and Biotechnology Companies
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Academic and Research Institutes
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Hospitals and Diagnostic Centers
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country
  • 6.5. Others
    • 6.5.1. Key market trends, growth factors and opportunities
    • 6.5.2. Market size and forecast, by region
    • 6.5.3. Market share analysis by country

CHAPTER 7: STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by Type
    • 7.2.3. Market size and forecast, by Application
    • 7.2.4. Market size and forecast, by End User
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Market size and forecast, by Type
      • 7.2.5.1.2. Market size and forecast, by Application
      • 7.2.5.1.3. Market size and forecast, by End User
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Market size and forecast, by Type
      • 7.2.5.2.2. Market size and forecast, by Application
      • 7.2.5.2.3. Market size and forecast, by End User
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Market size and forecast, by Type
      • 7.2.5.3.2. Market size and forecast, by Application
      • 7.2.5.3.3. Market size and forecast, by End User
  • 7.3. Europe
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by Type
    • 7.3.3. Market size and forecast, by Application
    • 7.3.4. Market size and forecast, by End User
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. Germany
      • 7.3.5.1.1. Market size and forecast, by Type
      • 7.3.5.1.2. Market size and forecast, by Application
      • 7.3.5.1.3. Market size and forecast, by End User
      • 7.3.5.2. France
      • 7.3.5.2.1. Market size and forecast, by Type
      • 7.3.5.2.2. Market size and forecast, by Application
      • 7.3.5.2.3. Market size and forecast, by End User
      • 7.3.5.3. UK
      • 7.3.5.3.1. Market size and forecast, by Type
      • 7.3.5.3.2. Market size and forecast, by Application
      • 7.3.5.3.3. Market size and forecast, by End User
      • 7.3.5.4. Italy
      • 7.3.5.4.1. Market size and forecast, by Type
      • 7.3.5.4.2. Market size and forecast, by Application
      • 7.3.5.4.3. Market size and forecast, by End User
      • 7.3.5.5. Spain
      • 7.3.5.5.1. Market size and forecast, by Type
      • 7.3.5.5.2. Market size and forecast, by Application
      • 7.3.5.5.3. Market size and forecast, by End User
      • 7.3.5.6. Rest of Europe
      • 7.3.5.6.1. Market size and forecast, by Type
      • 7.3.5.6.2. Market size and forecast, by Application
      • 7.3.5.6.3. Market size and forecast, by End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by Type
    • 7.4.3. Market size and forecast, by Application
    • 7.4.4. Market size and forecast, by End User
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. Japan
      • 7.4.5.1.1. Market size and forecast, by Type
      • 7.4.5.1.2. Market size and forecast, by Application
      • 7.4.5.1.3. Market size and forecast, by End User
      • 7.4.5.2. China
      • 7.4.5.2.1. Market size and forecast, by Type
      • 7.4.5.2.2. Market size and forecast, by Application
      • 7.4.5.2.3. Market size and forecast, by End User
      • 7.4.5.3. India
      • 7.4.5.3.1. Market size and forecast, by Type
      • 7.4.5.3.2. Market size and forecast, by Application
      • 7.4.5.3.3. Market size and forecast, by End User
      • 7.4.5.4. Australia
      • 7.4.5.4.1. Market size and forecast, by Type
      • 7.4.5.4.2. Market size and forecast, by Application
      • 7.4.5.4.3. Market size and forecast, by End User
      • 7.4.5.5. Rest of Asia-Pacific
      • 7.4.5.5.1. Market size and forecast, by Type
      • 7.4.5.5.2. Market size and forecast, by Application
      • 7.4.5.5.3. Market size and forecast, by End User
  • 7.5. LAMEA
    • 7.5.1. Key market trends, growth factors and opportunities
    • 7.5.2. Market size and forecast, by Type
    • 7.5.3. Market size and forecast, by Application
    • 7.5.4. Market size and forecast, by End User
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Brazil
      • 7.5.5.1.1. Market size and forecast, by Type
      • 7.5.5.1.2. Market size and forecast, by Application
      • 7.5.5.1.3. Market size and forecast, by End User
      • 7.5.5.2. South Africa,
      • 7.5.5.2.1. Market size and forecast, by Type
      • 7.5.5.2.2. Market size and forecast, by Application
      • 7.5.5.2.3. Market size and forecast, by End User
      • 7.5.5.3. Saudi Arabia
      • 7.5.5.3.1. Market size and forecast, by Type
      • 7.5.5.3.2. Market size and forecast, by Application
      • 7.5.5.3.3. Market size and forecast, by End User
      • 7.5.5.4. Rest of LAMEA
      • 7.5.5.4.1. Market size and forecast, by Type
      • 7.5.5.4.2. Market size and forecast, by Application
      • 7.5.5.4.3. Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product mapping of top 10 player
  • 8.4. Competitive dashboard
  • 8.5. Competitive heatmap
  • 8.6. Top player positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. Merck KGaA
    • 9.1.1. Company overview
    • 9.1.2. Key executives
    • 9.1.3. Company snapshot
    • 9.1.4. Operating business segments
    • 9.1.5. Product portfolio
    • 9.1.6. Business performance
    • 9.1.7. Key strategic moves and developments
  • 9.2. Otsuka Holdings Co., Ltd.
    • 9.2.1. Company overview
    • 9.2.2. Key executives
    • 9.2.3. Company snapshot
    • 9.2.4. Operating business segments
    • 9.2.5. Product portfolio
    • 9.2.6. Business performance
    • 9.2.7. Key strategic moves and developments
  • 9.3. Entegris
    • 9.3.1. Company overview
    • 9.3.2. Key executives
    • 9.3.3. Company snapshot
    • 9.3.4. Operating business segments
    • 9.3.5. Product portfolio
    • 9.3.6. Business performance
  • 9.4. Omicron Biochemicals, Inc.
    • 9.4.1. Company overview
    • 9.4.2. Key executives
    • 9.4.3. Company snapshot
    • 9.4.4. Operating business segments
    • 9.4.5. Product portfolio
  • 9.5. Shimadzu Corporation
    • 9.5.1. Company overview
    • 9.5.2. Key executives
    • 9.5.3. Company snapshot
    • 9.5.4. Operating business segments
    • 9.5.5. Product portfolio
    • 9.5.6. Business performance
  • 9.6. Silantes
    • 9.6.1. Company overview
    • 9.6.2. Key executives
    • 9.6.3. Company snapshot
    • 9.6.4. Operating business segments
    • 9.6.5. Product portfolio
  • 9.7. VIVAN Life Sciences
    • 9.7.1. Company overview
    • 9.7.2. Key executives
    • 9.7.3. Company snapshot
    • 9.7.4. Operating business segments
    • 9.7.5. Product portfolio
  • 9.8. BOC Sciences
    • 9.8.1. Company overview
    • 9.8.2. Key executives
    • 9.8.3. Company snapshot
    • 9.8.4. Operating business segments
    • 9.8.5. Product portfolio
  • 9.9. Symeres
    • 9.9.1. Company overview
    • 9.9.2. Key executives
    • 9.9.3. Company snapshot
    • 9.9.4. Operating business segments
    • 9.9.5. Product portfolio
  • 9.10. NIPPON SANSO HOLDINGS CORPORATION
    • 9.10.1. Company overview
    • 9.10.2. Key executives
    • 9.10.3. Company snapshot
    • 9.10.4. Operating business segments
    • 9.10.5. Product portfolio
    • 9.10.6. Business performance